Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, June 9, 2026, 1:00–2:00 PM ET
In this webinar, we will examine how immune recognition after allogeneic HCT can influence leukemia relapse and disease progression. The session will highlight the clinical relevance of HLA loss of heterozygosity (LOH), approaches used for its detection, and how LOH findings may support transplant strategies, including considerations for donor selection in subsequent transplantation.
Webinar presenter Alberto Cardoso Martins Lima, PhD, Clinical consulting scientist in histocompatibility,
specializing in allogeneic hematopoietic cell transplantation (HCT) at IGEN/AFIP São Paulo and CHC/UFPR in Curitiba, Brazil
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenter Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
The HardyChrom SS, from Hardy Diagnostics, is a selective chromogenic medium recommended for use as a primary screening medium for isolating and differentiating Salmonella and Shigella spp from stool cultures.
Sarstedt collection products for arterial and capillary blood gas determinations, consisting of 1-mL and 2-mL plastic blood gas syringes, contain a fine dispersion of calcium-balanced heparin, resulting in a large surface area for good solubility and quick mixing.
Dualsystems Biotech’s DualMembrane system detects novel interaction partners for membrane proteins and can be used to detect pairwise protein interactions, identify novel protein interactions by cDNA library screening, investigate ternary complexes, and map interaction domains. The system is available as a kit or custom screening service.
Bio SB now offers HRP Green, a vibrant chromogen to help clinical and research laboratories detect IHC markers on paraffin-embedded tissues. HRP Green comes in a two-part buffer and chromogen format that is compatible with all Bio SB polymer and biotin HRP-based detection systems. HRP Green requires a five-minute incubation period, can be counterstained with Nuclear Fast Red or hematoxylin, and is xylene (PermaMounter) compatible.
August 2013—Vector Laboratories now offers glycoprotein eluting solutions and neoglycoproteins. Five glycoprotein eluting solutions have been generated to complement the company’s range of agarose-bound lectins. These solutions maximize the yield of eluted glycoproteins from the beads and preserve lectin activity for repeat use.
Hamilton Robotics has a new module for its Microlab Star workstation that automates enzyme-linked immunoabsorbant assays (ELISAs). The ELISA StarLet module integrates precision liquid handling instrumentation with multiple devices and sophisticated software.
Leica Biosystems, in partnership with Indica Labs, has launched the HALO next-generation image-analysis software. The HALO platform is fast, scalable, and user-friendly and is for Aperio ePathology image analysis.
Beckman Coulter’s Microfuge 20 and 20R microcentrifuges are designed to meet the specific requirements of a range of research applications and are easy to use. Paired with Microfuge series rotors, the microcentrifuges provide flexibility and reliable, precise performance while occupying a small footprint.
Ventana Medical Systems has signed a worldwide agreement with health care imaging expert Barco to provide Barco’s diagnostic and clinical review display systems for use with Ventana’s Virtuoso image and workflow management system.
Health Canada has approved Life Technologies’ Applied Biosystems 3500 Dx/3500xL Dx genetic analyzers CS2 for diagnostic use. The Applied Biosystems 3500 Dx series genetic analyzers deliver high-quality performance, high throughput, and increased productivity for clinical laboratories. The 3500xL Dx is an automated 24-capillary-based Sanger sequencer; the 3500 Dx is an eight-capillary instrument.
